Vaxine RSV Vaccine
Respiratory Syncytial Virus
Phase 1Active
Key Facts
About Vaxine
AI‑enhanced vaccine developer using the Advax™ adjuvant platform for infectious disease and immunotherapy.
View full company profileTherapeutic Areas
Other Respiratory Syncytial Virus Drugs
| Drug | Company | Phase |
|---|---|---|
| RSV Vaccine | Artificial Cell Technologies | Pre-clinical |
| MDL-001 | Model Medicines | Preclinical |
| MNM‑siRNA RSV | Interna TX | Preclinical |
| AdRSV‑F | Adimmune | Preclinical |